CIK 0001600620
- Large accelerated filer
Aurinia Pharmaceuticals Inc.
Sign in to watch- Ticker
- AUPH
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Entity type
- Operating
- EIN
- 981231763
- Phone
- +1 250-744-2487
- Business address
- #140, 14315 - 118 AVENUE, EDMONTON, Alberta, Canada, T5L 4S6
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $735,889
- in 3 filings
Net −$735,889. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2021-01-29 | Hayden Michael R Director | Option exercise | +15,000 | $6.42 | $96K | 95,000 |
| 2021-01-29 | Hayden Michael R Director | Option exercise · Stock Option (right to buy) | −50,000 | 0 | ||
| 2021-01-29 | Hayden Michael R Director | Option exercise · Stock Option (right to buy) | −30,000 | 0 | ||
| 2021-01-29 | Hayden Michael R Director | Option exercise · Stock Option (right to buy) | −15,000 | 0 | ||
| 2021-01-28 | Robertson Stephen P. EVP, General Counsel | Purchase | +900 | $16.14 | $15K | 2,720 |
Page 18 of 18 · 345 trades